Cleo Diagnostics Ltd has released a press release.
Corporate Presentation
Filed with ASX ·
6ix hasn’t read this filing yet.
In the deck
Earlier from CLEO Diagnostics
- Cleo Advances with Completion of Alpha Testing
- CLEO to Fast Track Development of Ovarian Cancer Test
- CLEO Receives A$845k Research and Development Tax Incentive
- CLEO Delivers Commercial Development Milestone
- Price Query Response
Later from CLEO Diagnostics
- CLEO Strengthens FDA Submission - Access to US Biobank
- COV Commences Health Economic Study-Support US Market Entry
- Appendix 4E and 2025 Annual Report
- Cleo Receives Positive FDA Feedback
- CLEO Successfully Completes Stage 1 MDSAP Audit
Follow CLEO Diagnostics into a list and get an email when it puts out news.
Follow CLEO Diagnostics